IGF2BP1 is a potent oncogenic factor, and enhanced expression of IGF2BP1 was associated with malignant phenotypes in CRC cell lines and poor prognosis in CRC patients. This evidence concerns the gene IGF2BP1 and colorectal carcinoma.